{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:50:30Z","timestamp":1791532230368,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-68086-5","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T01:23:20Z","timestamp":1766625800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Calcium channel blockers increase the risk of aortic aneurysm and dissection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7571-0996","authenticated-orcid":false,"given":"Tianfeng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8832-9331","authenticated-orcid":false,"given":"Yi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-4901","authenticated-orcid":false,"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-3906","authenticated-orcid":false,"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-6509","authenticated-orcid":false,"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-8390","authenticated-orcid":false,"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-6810","authenticated-orcid":false,"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"68086_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1001\/jama.2023.5592","volume":"330","author":"JR Baman","year":"2023","unstructured":"Baman, J. R. & Malaisrie, S. C. What Is Aortic Dissection? JAMA 330, 198 (2023).","journal-title":"JAMA"},{"key":"68086_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","volume":"57","author":"A Wanhainen","year":"2019","unstructured":"Wanhainen, A. et al. Editor\u2019s Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur. J. Vasc. Endovasc. Surg. 57, 8\u201393 (2019).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"68086_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCRESAHA.118.312436","volume":"124","author":"A Pinard","year":"2019","unstructured":"Pinard, A., Jones, G. T. & Milewicz, D. M. Genetics of Thoracic and Abdominal Aortic Diseases. Circ. Res 124, 588\u2013606 (2019).","journal-title":"Circ. Res"},{"key":"68086_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jama.2023.0265","volume":"329","author":"I Hameed","year":"2023","unstructured":"Hameed, I., Cifu, A. S. & Vallabhajosyula, P. Management of Thoracic Aortic Dissection. JAMA 329, 756\u2013757 (2023).","journal-title":"JAMA"},{"key":"68086_CR5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1001\/jamacardio.2020.3524","volume":"5","author":"J Golledge","year":"2020","unstructured":"Golledge, J. et al. Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA Cardiol. 5, 1374\u20131381 (2020).","journal-title":"JAMA Cardiol."},{"key":"68086_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X16999201102213619","volume":"17","author":"JA Siordia","year":"2021","unstructured":"Siordia, J. A. Beta-Blockers and Abdominal Aortic Aneurysm Growth: A Systematic Review and Meta-Analysis. Curr. Cardiol. Rev. 17, e230421187502 (2021).","journal-title":"Curr. Cardiol. Rev."},{"key":"68086_CR7","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/eurheartj\/ehw257","volume":"37","author":"CD Bicknell","year":"2016","unstructured":"Bicknell, C. D., Kiru, G., Falaschetti, E., Powell, J. T. & Poulter, N. R. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK). Eur. Heart J. 37, 3213\u20133221 (2016).","journal-title":"Eur. Heart J."},{"key":"68086_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009866","volume":"7","author":"JL Pinchbeck","year":"2018","unstructured":"Pinchbeck, J. L. et al. Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME -2 Trial. J. Am. Heart Assoc. 7, e009866 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"68086_CR9","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/bjs.9824","volume":"102","author":"H Sillesen","year":"2015","unstructured":"Sillesen, H. et al. Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br. J. Surg. 102, 894\u2013901 (2015).","journal-title":"Br. J. Surg."},{"key":"68086_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1001\/jama.2020.5230","volume":"323","author":"BT Baxter","year":"2020","unstructured":"Baxter, B. T. et al. Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA 323, 2029\u20132038 (2020).","journal-title":"JAMA"},{"key":"68086_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jvs.2008.12.048","volume":"50","author":"L Karlsson","year":"2009","unstructured":"Karlsson, L., Gnarpe, J., Bergqvist, D., Lindb\u00e4ck, J. & P\u00e4rsson, H. The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms-a prospective randomized double-blind trial. J. Vasc. Surg. 50, 23\u201329 (2009).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR12","first-page":"450","volume":"116","author":"A Wanhainen","year":"2020","unstructured":"Wanhainen, A. et al. The effect of ticagrelor on growth of small abdominal aortic aneurysms-a randomized controlled trial. Cardiovasc Res 116, 450\u2013456 (2020).","journal-title":"Cardiovasc Res"},{"key":"68086_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/CIRCULATIONAHA.121.056546","volume":"145","author":"M Hibino","year":"2022","unstructured":"Hibino, M. et al. Blood Pressure, Hypertension, and the Risk of Aortic Dissection Incidence and Mortality: Results From the J-SCH Study, the UK Biobank Study, and a Meta-Analysis of Cohort Studies. Circulation 145, 633\u2013644 (2022).","journal-title":"Circulation"},{"key":"68086_CR14","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki, E. et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people. Lancet 383, 1899\u20131911 (2014).","journal-title":"Lancet"},{"key":"68086_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1253026","volume":"344","author":"JD Humphrey","year":"2014","unstructured":"Humphrey, J. D., Milewicz, D. M., Tellides, G. & Schwartz, M. A. Cell biology. Dysfunctional mechanosensing in aneurysms. Science 344, 477\u2013479 (2014).","journal-title":"Science"},{"key":"68086_CR16","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jtcvs.2009.07.075","volume":"138","author":"G Ailawadi","year":"2009","unstructured":"Ailawadi, G. et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc Surg. 138, 1392\u20131399 (2009).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"68086_CR17","doi-asserted-by":"crossref","unstructured":"Ostberg, N. P., Zafar, M. A., Ziganshin, B. A. & Elefteriades, J. A. The Genetics of Thoracic Aortic Aneurysms and Dissection: A Clinical Perspective. Biomolecules 10, 182 (2020).","DOI":"10.3390\/biom10020182"},{"key":"68086_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/ATVBAHA.116.303229","volume":"37","author":"DM Milewicz","year":"2017","unstructured":"Milewicz, D. M. et al. Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections. Arterioscler Thromb. Vasc. Biol. 37, 26\u201334 (2017).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"68086_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27874-5","volume":"13","author":"W Qian","year":"2022","unstructured":"Qian, W. et al. Microskeletal stiffness promotes aortic aneurysm by sustaining pathological vascular smooth muscle cell mechanosensation via Piezo1. Nat. Commun. 13, 512 (2022).","journal-title":"Nat. Commun."},{"key":"68086_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165587","volume":"1866","author":"P Nolasco","year":"2020","unstructured":"Nolasco, P. et al. Impaired vascular smooth muscle cell force-generating capacity and phenotypic deregulation in Marfan Syndrome mice. Biochim Biophys. Acta Mol. Basis Dis. 1866, 165587 (2020).","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"68086_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.ehj.2004.04.033","volume":"25","author":"GJ Nollen","year":"2004","unstructured":"Nollen, G. J., Groenink, M., Tijssen, J. G., Van Der Wall, E. E. & Mulder, B. J. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur. Heart J. 25, 1146\u20131152 (2004).","journal-title":"Eur. Heart J."},{"key":"68086_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/13543776.2018.1541982","volume":"28","author":"G Nam","year":"2018","unstructured":"Nam, G. T-type calcium channel blockers: a patent review (2012-2018). Expert Opin. Ther. Pat. 28, 883\u2013901 (2018).","journal-title":"Expert Opin. Ther. Pat."},{"key":"68086_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/HYPERTENSIONAHA.109.140558","volume":"55","author":"Y Kanematsu","year":"2010","unstructured":"Kanematsu, Y. et al. Pharmacologically induced thoracic and abdominal aortic aneurysms in mice. Hypertension 55, 1267\u20131274 (2010).","journal-title":"Hypertension"},{"key":"68086_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/HYPERTENSIONAHA.113.01986","volume":"62","author":"A Mieth","year":"2013","unstructured":"Mieth, A. et al. L-type calcium channel inhibitor diltiazem prevents aneurysm formation by blood pressure-independent anti-inflammatory effects. Hypertension 62, 1098\u20131104 (2013).","journal-title":"Hypertension"},{"key":"68086_CR25","doi-asserted-by":"publisher","first-page":"e81743","DOI":"10.1371\/journal.pone.0081743","volume":"8","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. PLoS One 8, e81743 (2013).","journal-title":"PLoS One"},{"key":"68086_CR26","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jtcvs.2013.02.073","volume":"146","author":"H Kurobe","year":"2013","unstructured":"Kurobe, H. et al. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects. J. Thorac. Cardiovasc Surg. 146, 1501\u20131508 (2013).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"68086_CR27","doi-asserted-by":"crossref","unstructured":"Doyle, J. J. et al. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife 4, e08648 (2015).","DOI":"10.7554\/eLife.08648"},{"key":"68086_CR28","unstructured":"in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (National Institute of Diabetes and Digestive and Kidney Diseases, (2012)."},{"key":"68086_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-physiol-042022-031925","volume":"86","author":"V Regnault","year":"2024","unstructured":"Regnault, V., Lacolley, P. & Laurent, S. Arterial Stiffness: From Basic Primers to Integrative Physiology. Annu Rev. Physiol. 86, 99\u2013121 (2024).","journal-title":"Annu Rev. Physiol."},{"key":"68086_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jvs.2019.11.013","volume":"71","author":"JV Lombardi","year":"2020","unstructured":"Lombardi, J. V. et al. Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) reporting standards for type B aortic dissections. J. Vasc. Surg. 71, 723\u2013747 (2020).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR31","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/bph.15694","volume":"179","author":"M Toral","year":"2022","unstructured":"Toral, M., de la Fuente-Alonso, A., Campanero, M. R. & Redondo, J. M. The NO signalling pathway in aortic aneurysm and dissection. Br. J. Pharm. 179, 1287\u20131303 (2022).","journal-title":"Br. J. Pharm."},{"key":"68086_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11389-1","volume":"10","author":"GK Schwaerzer","year":"2019","unstructured":"Schwaerzer, G. K. et al. Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B(12) analog. Nat. Commun. 10, 3533 (2019).","journal-title":"Nat. Commun."},{"key":"68086_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajhg.2013.06.019","volume":"93","author":"DC Guo","year":"2013","unstructured":"Guo, D. C. et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am. J. Hum. Genet 93, 398\u2013404 (2013).","journal-title":"Am. J. Hum. Genet"},{"key":"68086_CR34","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","volume":"34","author":"M Groenink","year":"2013","unstructured":"Groenink, M. et al. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur. Heart J. 34, 3491\u20133500 (2013).","journal-title":"Eur. Heart J."},{"key":"68086_CR35","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0140-6736(19)32518-8","volume":"394","author":"M Mullen","year":"2019","unstructured":"Mullen, M. et al. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet 394, 2263\u20132270 (2019).","journal-title":"Lancet"},{"key":"68086_CR36","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro, R. V. et al. Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome. N. Engl. J. Med 371, 2061\u20132071 (2014).","journal-title":"N. Engl. J. Med"},{"key":"68086_CR37","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1093\/eurheartj\/ehaa377","volume":"41","author":"MM van Andel","year":"2020","unstructured":"van Andel, M. M. et al. Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial. Eur. Heart J. 41, 4181\u20134187 (2020).","journal-title":"Eur. Heart J."},{"key":"68086_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","volume":"88","author":"HH Chiu","year":"2013","unstructured":"Chiu, H. H. et al. Losartan added to \u03b2-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study. Mayo Clin. Proc. 88, 271\u2013276 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"68086_CR39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","volume":"330","author":"J Shores","year":"1994","unstructured":"Shores, J., Berger, K. R., Murphy, E. A. & Pyeritz, R. E. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan\u2019s syndrome. N. Engl. J. Med 330, 1335\u20131341 (1994).","journal-title":"N. Engl. J. Med"},{"key":"68086_CR40","doi-asserted-by":"publisher","first-page":"E334","DOI":"10.1161\/CIR.0000000000001106","volume":"146","author":"EM Isselbacher","year":"2022","unstructured":"Isselbacher, E. M. et al. 2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 146, E334\u2013E482 (2022).","journal-title":"Circulation"},{"key":"68086_CR41","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai, L. et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur. Heart J. 45, 3538\u20133700 (2024).","journal-title":"Eur. Heart J."},{"key":"68086_CR42","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0140-6736(22)01534-3","volume":"400","author":"A Pitcher","year":"2022","unstructured":"Pitcher, A. et al. Angiotensin receptor blockers and \u03b2 blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. Lancet 400, 822\u2013831 (2022).","journal-title":"Lancet"},{"key":"68086_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature19102","volume":"537","author":"L Tang","year":"2016","unstructured":"Tang, L. et al. Structural basis for inhibition of a voltage-gated Ca(2+) channel by Ca(2+) antagonist drugs. Nature 537, 117\u2013121 (2016).","journal-title":"Nature"},{"key":"68086_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","volume":"37","author":"GH Hockerman","year":"1997","unstructured":"Hockerman, G. H., Peterson, B. Z., Johnson, B. D. & Catterall, W. A. Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev. Pharm. Toxicol. 37, 361\u2013396 (1997).","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"68086_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","volume":"74","author":"DJ Triggle","year":"2007","unstructured":"Triggle, D. J. Calcium channel antagonists: clinical uses-past, present and future. Biochem Pharm. 74, 1\u20139 (2007).","journal-title":"Biochem Pharm."},{"key":"68086_CR46","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1067\/mva.2001.112810","volume":"33","author":"S Liao","year":"2001","unstructured":"Liao, S. et al. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J. Vasc. Surg. 33, 1057\u20131064 (2001).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR47","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/ATVBAHA.112.300820","volume":"33","author":"S Liu","year":"2013","unstructured":"Liu, S. et al. Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt. Arterioscler Thromb. Vasc. Biol. 33, 1568\u20131579 (2013).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"68086_CR48","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/ATVBAHA.122.317712","volume":"42","author":"H Sawada","year":"2022","unstructured":"Sawada, H. et al. Inhibition of the Renin-Angiotensin System Fails to Suppress \u03b2-Aminopropionitrile-Induced Thoracic Aortopathy in Mice-Brief Report. Arterioscler Thromb. Vasc. Biol. 42, 1254\u20131261 (2022).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"68086_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/ng1721","volume":"38","author":"L Zhu","year":"2006","unstructured":"Zhu, L. et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm\/aortic dissection and patent ductus arteriosus. Nat. Genet 38, 343\u2013349 (2006).","journal-title":"Nat. Genet"},{"key":"68086_CR50","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/ng.2007.6","volume":"39","author":"DC Guo","year":"2007","unstructured":"Guo, D. C. et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet 39, 1488\u20131493 (2007).","journal-title":"Nat. Genet"},{"key":"68086_CR51","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajhg.2010.10.006","volume":"87","author":"L Wang","year":"2010","unstructured":"Wang, L. et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am. J. Hum. Genet 87, 701\u2013707 (2010).","journal-title":"Am. J. Hum. Genet"},{"key":"68086_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/nm.4364","volume":"23","author":"G de C\u00e1rcer","year":"2017","unstructured":"de C\u00e1rcer, G. et al. Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis. Nat. Med 23, 964\u2013974 (2017).","journal-title":"Nat. Med"},{"key":"68086_CR53","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023053","volume":"11","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Mohan, A., Shi, H. & Yan, C. Sildenafil (Viagra) Aggravates the Development of Experimental Abdominal Aortic Aneurysm. J. Am. Heart Assoc. 11, e023053 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"68086_CR54","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.107.156976","volume":"101","author":"L Yang","year":"2007","unstructured":"Yang, L. et al. Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits. Circ. Res. 101, 465\u2013474 (2007).","journal-title":"Circ. Res"},{"key":"68086_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22933-3","volume":"12","author":"A de la Fuente-Alonso","year":"2021","unstructured":"de la Fuente-Alonso, A. et al. Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO. Nat. Commun. 12, 2628 (2021).","journal-title":"Nat. Commun."},{"key":"68086_CR56","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0741-5214(02)00129-5","volume":"36","author":"AB Wilmink","year":"2002","unstructured":"Wilmink, A. B. et al. Are antihypertensive drugs associated with abdominal aortic aneurysms? J. Vasc. Surg. 36, 751\u2013757 (2002).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR57","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.114.012377","volume":"131","author":"U Raaz","year":"2015","unstructured":"Raaz, U. et al. Segmental aortic stiffening contributes to experimental abdominal aortic aneurysm development. Circulation 131, 1783\u20131795 (2015).","journal-title":"Circulation"},{"key":"68086_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12013-007-9002-3","volume":"50","author":"JD Humphrey","year":"2008","unstructured":"Humphrey, J. D. Vascular adaptation and mechanical homeostasis at tissue, cellular, and sub-cellular levels. Cell Biochem Biophys. 50, 53\u201378 (2008).","journal-title":"Cell Biochem Biophys."},{"key":"68086_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/CS20060337","volume":"113","author":"D Dajnowiec","year":"2007","unstructured":"Dajnowiec, D. & Langille, B. L. Arterial adaptations to chronic changes in haemodynamic function: coupling vasomotor tone to structural remodelling. Clin. Sci. (Lond.) 113, 15\u201323 (2007).","journal-title":"Clin. Sci. (Lond.)"},{"key":"68086_CR60","doi-asserted-by":"crossref","unstructured":"Dai, C. & Khalil, R. A. Calcium Signaling Dynamics in Vascular Cells and Their Dysregulation in Vascular Disease. Biomolecules 15, 892 (2025).","DOI":"10.3390\/biom15060892"},{"key":"68086_CR61","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ahj.2006.07.024","volume":"152","author":"H Yang","year":"2006","unstructured":"Yang, H., Raymer, K., Butler, R., Parlow, J. & Roberts, R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am. Heart J. 152, 983\u2013990 (2006).","journal-title":"Am. Heart J."},{"key":"68086_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.23736\/S0392-9590.22.04847-7","volume":"41","author":"M Ra\u0161iov\u00e1","year":"2022","unstructured":"Ra\u0161iov\u00e1, M. et al. Positive association between calcium channel blocker treatment and persistent type II endoleak. Int Angiol. 41, 277\u2013284 (2022).","journal-title":"Int Angiol."},{"key":"68086_CR63","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/bja\/aen173","volume":"101","author":"MD Kertai","year":"2008","unstructured":"Kertai, M. D., Westerhout, C. M., Varga, K. S., Acsady, G. & Gal, J. Dihydropiridine calcium-channel blockers and perioperative mortality in aortic aneurysm surgery. Br. J. Anaesth. 101, 458\u2013465 (2008).","journal-title":"Br. J. Anaesth."},{"key":"68086_CR64","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12630-010-9330-4","volume":"57","author":"CJ Railton","year":"2010","unstructured":"Railton, C. J., Wolpin, J., Lam-McCulloch, J. & Belo, S. E. Renin-angiotensin blockade is associated with increased mortality after vascular surgery. Can. J. Anaesth. 57, 736\u2013744 (2010).","journal-title":"Can. J. Anaesth."},{"key":"68086_CR65","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jvs.2012.03.263","volume":"56","author":"F Bastos Gon\u00e7alves","year":"2012","unstructured":"Bastos Gon\u00e7alves, F. et al. Clinical outcome and morphologic analysis after endovascular aneurysm repair using the Excluder endograft. J. Vasc. Surg. 56, 920\u2013928 (2012).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jvs.2016.06.111","volume":"65","author":"W Kim","year":"2017","unstructured":"Kim, W. et al. Effect of \u03b2-blocker on aneurysm sac behavior after endovascular abdominal aortic repair. J. Vasc. Surg. 65, 337\u2013345 (2017).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR67","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/SLA.0000000000002291","volume":"267","author":"HN Alshaikh","year":"2018","unstructured":"Alshaikh, H. N., Canner, J. K. & Malas, M. Effect of Beta Blockers on Mortality After Open Repair of Abdominal Aortic Aneurysm. Ann. Surg. 267, 1185\u20131190 (2018).","journal-title":"Ann. Surg."},{"key":"68086_CR68","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.jtcvs.2019.05.032","volume":"159","author":"SW Chen","year":"2020","unstructured":"Chen, S. W. et al. Effect of \u03b2-blocker therapy on late outcomes after surgical repair of type A aortic dissection. J. Thorac. Cardiovasc Surg. 159, 1694\u20131703.e1693 (2020).","journal-title":"J. Thorac. Cardiovasc Surg."},{"key":"68086_CR69","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.avsg.2021.07.056","volume":"80","author":"B Nejim","year":"2022","unstructured":"Nejim, B., Mathlouthi, A., Naazie, I. & Malas, M. B. The Effect of Intravenous and Oral Beta-Blocker Use in Patients with Type B Thoracic Aortic Dissection. Ann. Vasc. Surg. 80, 170\u2013179 (2022).","journal-title":"Ann. Vasc. Surg."},{"key":"68086_CR70","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.jvs.2022.06.100","volume":"76","author":"H Chang","year":"2022","unstructured":"Chang, H. et al. Beta-blocker use after thoracic endovascular aortic repair in patients with type B aortic dissection is associated with improved early aortic remodeling. J. Vasc. Surg. 76, 1477\u20131485.e1472 (2022).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1291900","volume":"14","author":"KM Laio","year":"2023","unstructured":"Laio, K. M. et al. Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery. Front Pharm. 14, 1291900 (2023).","journal-title":"Front Pharm."},{"key":"68086_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029761","volume":"12","author":"N Elsayed","year":"2023","unstructured":"Elsayed, N., Gaffey, A. C., Abou-Zamzam, A. & Malas, M. B. Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Favorable Outcomes Compared to Beta Blockers in Reducing Mortality Following Abdominal Aneurysm Repair. J. Am. Heart Assoc. 12, e029761 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"68086_CR73","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.avsg.2024.07.104","volume":"110","author":"R Vicario-Feliciano","year":"2025","unstructured":"Vicario-Feliciano, R., Zil, E. A. A. & Aziz, F. Beta Blockers are Associated with Increased Mortality Without a Decrease in Reinterventions After Endovascular Abdominal Aortic Repair (EVAR). Ann. Vasc. Surg. 110, 395\u2013404 (2025).","journal-title":"Ann. Vasc. Surg."},{"key":"68086_CR74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jvs.2017.06.075","volume":"67","author":"SE Deery","year":"2018","unstructured":"Deery, S. E. et al. Aneurysm sac expansion is independently associated with late mortality in patients treated with endovascular aneurysm repair. J. Vasc. Surg. 67, 157\u2013164 (2018).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR75","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jvs.2018.04.050","volume":"69","author":"TFX O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell, T. F. X. et al. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J. Vasc. Surg. 69, 414\u2013422 (2019).","journal-title":"J. Vasc. Surg."},{"key":"68086_CR76","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.medj.2020.11.001","volume":"2","author":"SM Zekavat","year":"2021","unstructured":"Zekavat, S. M. et al. Elevated Blood Pressure Increases Pneumonia Risk: Epidemiological Association and Mendelian Randomization in the UK Biobank. Med 2, 137\u2013148.e134 (2021).","journal-title":"Med"},{"key":"68086_CR77","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/jamaophthalmol.2023.3877","volume":"141","author":"A Kastner","year":"2023","unstructured":"Kastner, A. et al. Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants. JAMA Ophthalmol. 141, 956\u2013964 (2023).","journal-title":"JAMA Ophthalmol."},{"key":"68086_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101072","volume":"4","author":"Y Shen","year":"2023","unstructured":"Shen, Y. et al. Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension. Cell Rep. Med 4, 101072 (2023).","journal-title":"Cell Rep. Med"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68086-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:02:32Z","timestamp":1770217352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-68086-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68086"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-68086-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1334"}}